Skip to main content
Erschienen in: Pediatric Cardiology 8/2022

18.05.2022 | Original Article

QTc and QRS Abnormalities are Associated with Outcome in Pediatric Heart Failure

verfasst von: Kandice Mah, Shiyi Chen, Gursimran Chandhoke, Paul F. Kantor, Elizabeth Stephenson

Erschienen in: Pediatric Cardiology | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Adult studies have shown that depolarization and repolarization abnormalities are associated with worsening heart failure; however, this relationship is not well understood in pediatric congenital heart disease. We evaluated the association between QTc and QRS duration to systolic function and outcome in children with heart failure and reduced ejection fraction (HFrEF). We performed a retrospective, single-center, 14-year cohort study of HFrEF children. Clinical records, echocardiograms, and electrocardiograms were reviewed for every clinical encounter. Diagnosis, interventions, outcomes, QRS and QTc duration, and systolic function were collected. Repeated-measure ANOVA evaluated the association between depolarization and repolarization to cardiac function. Cox regression analysis examined the effects of age, time since diagnosis, and measured and change in QTc and QRS duration on time to transplant/death. We enrolled 136 cardiomyopathy (CM) and 47 structural heart disease (SHD) patients. Prolonged QRS (p = 0.0001) and QTc (p = 0.02) were associated with systolic dysfunction. This association was significant in SHD group (QRS p < 0.0001, QTc p = 0.048), but not CM group (QRS p = 0.5, QTc p = 0.3). Progressive lengthening of QTc was significantly associated with transplant or death in the overall cohort (HR 1.02, CI 1.011–1.028), SHD, (HR 1.020, CI 1.001–1.039), and CM (HR 1.017, CI 1.007–1.027). QTc and QRS prolongation are each associated with ventricular dysfunction in pediatric SHD with heart failure. QTc prolongation is an indication for poor outcomes in SHD and CM groups, leading to a higher risk of death or transplantation. Progressive lengthening of QTc over time in children with HFrEF may indicate increased risk in this population.
Literatur
1.
Zurück zum Zitat Zhang ZM, Rautaharju PM, Soliman EZ, Manson JE, Martin LW, Perez M, Vitolins M, Prineas RJ (2013) Different patterns of bundle-branch blocks and the risk of incident heart failure in the women’s health initiative (WHI) study. Circ Heart Fail 6:655–661CrossRef Zhang ZM, Rautaharju PM, Soliman EZ, Manson JE, Martin LW, Perez M, Vitolins M, Prineas RJ (2013) Different patterns of bundle-branch blocks and the risk of incident heart failure in the women’s health initiative (WHI) study. Circ Heart Fail 6:655–661CrossRef
2.
Zurück zum Zitat Abdel-Qadir HM, Tu JV, Austin PC, Wang JT, Lee DS (2011) Bundle branch block patterns and long-term outcomes in heart failure. Int J Cardiol 146:213–218CrossRef Abdel-Qadir HM, Tu JV, Austin PC, Wang JT, Lee DS (2011) Bundle branch block patterns and long-term outcomes in heart failure. Int J Cardiol 146:213–218CrossRef
3.
Zurück zum Zitat Rautaharju PM, Zhang ZM, Haisty WK, Prineas RJ, Kucharska-Newton AM, Rosamond WD, Soliman EZ (2013) Electrocardiographic predictors of incident heart failure in men and women free from manifest cardiovascular disease (from the atherosclerosis risk in communities [ARIC] study). Am J Cardiol 112:843–849CrossRef Rautaharju PM, Zhang ZM, Haisty WK, Prineas RJ, Kucharska-Newton AM, Rosamond WD, Soliman EZ (2013) Electrocardiographic predictors of incident heart failure in men and women free from manifest cardiovascular disease (from the atherosclerosis risk in communities [ARIC] study). Am J Cardiol 112:843–849CrossRef
4.
Zurück zum Zitat Mikuz U, Poglajen G, Fister M, Starc V, Wu JC, Hisa H, Haddad F, Vrtovec B (2014) The presence of electromechanical mismatch in nonischemic dilated cardiomyopathy is associated with ventricular repolarization instability. J Card Fail 20:891–898CrossRef Mikuz U, Poglajen G, Fister M, Starc V, Wu JC, Hisa H, Haddad F, Vrtovec B (2014) The presence of electromechanical mismatch in nonischemic dilated cardiomyopathy is associated with ventricular repolarization instability. J Card Fail 20:891–898CrossRef
5.
Zurück zum Zitat Mah D, Wang A, Wu A, Alexander ME, Walsh EP (2012) Marked QT prolongation and ventricular tachycardia of a transient nature in young children with cardiomyopathy. Pacing Clin Electrophysiol 35:247–250CrossRef Mah D, Wang A, Wu A, Alexander ME, Walsh EP (2012) Marked QT prolongation and ventricular tachycardia of a transient nature in young children with cardiomyopathy. Pacing Clin Electrophysiol 35:247–250CrossRef
6.
Zurück zum Zitat Costello JM, Alexander ME, Greco KM, Perez-Atayde AR, Laussen PC (2009) Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics 123:835–841CrossRef Costello JM, Alexander ME, Greco KM, Perez-Atayde AR, Laussen PC (2009) Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics 123:835–841CrossRef
7.
Zurück zum Zitat Alp H, Baysal T, Altin H, Karatas Z, Karaaslan S (2014) QT and P-wave dispersions in rheumatic heart disease: prospective long-term follow up. Pediatr Int 56:681–688CrossRef Alp H, Baysal T, Altin H, Karatas Z, Karaaslan S (2014) QT and P-wave dispersions in rheumatic heart disease: prospective long-term follow up. Pediatr Int 56:681–688CrossRef
8.
Zurück zum Zitat Goodacre S, McLeod K (2002) Paediatric electrocardiography. BMJ 324:1382–1385CrossRef Goodacre S, McLeod K (2002) Paediatric electrocardiography. BMJ 324:1382–1385CrossRef
9.
Zurück zum Zitat Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP (2002) Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 21:684–688 Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP (2002) Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 21:684–688
10.
Zurück zum Zitat Janousek J (2009) Cardiac resynchronisation in congenital heart disease. Heart 95:940–947CrossRef Janousek J (2009) Cardiac resynchronisation in congenital heart disease. Heart 95:940–947CrossRef
11.
Zurück zum Zitat Jaffe LM, Morin DP (2014) Cardiac resynchronization therapy : history, present status, and future directions. Ochsner J 14:596–607PubMedPubMedCentral Jaffe LM, Morin DP (2014) Cardiac resynchronization therapy : history, present status, and future directions. Ochsner J 14:596–607PubMedPubMedCentral
12.
Zurück zum Zitat Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Susssman MA, Koch WJ (2012) Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 111:131–150CrossRef Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Susssman MA, Koch WJ (2012) Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 111:131–150CrossRef
13.
Zurück zum Zitat Long VP 3rd, Bonilla IM, Vargas-Pinto P, Nishijma Y, Sridhar A, Li C, Mowrey K, Wright P, Velayutham M, Kumar S, Lee NY, Zweier JL, Mohler PJ, Gyorke S, Carnes CA (2015) Heart failure duration progressively modulates the arrhythmia substrate through structural and electrical remodeling. Life Sci 123:61–71CrossRef Long VP 3rd, Bonilla IM, Vargas-Pinto P, Nishijma Y, Sridhar A, Li C, Mowrey K, Wright P, Velayutham M, Kumar S, Lee NY, Zweier JL, Mohler PJ, Gyorke S, Carnes CA (2015) Heart failure duration progressively modulates the arrhythmia substrate through structural and electrical remodeling. Life Sci 123:61–71CrossRef
14.
Zurück zum Zitat Pfeiffer ER, Tangney JR, Omens JH, McCulloch AD (2014) Biomechanics of cardiac electromechanical coupling and mechanoelectric feedback. J Biomech Eng 136:021007CrossRef Pfeiffer ER, Tangney JR, Omens JH, McCulloch AD (2014) Biomechanics of cardiac electromechanical coupling and mechanoelectric feedback. J Biomech Eng 136:021007CrossRef
15.
Zurück zum Zitat Smits JPP, Veldkamp MW, Wilde AAM (2005) Mechanisms of inherited cardiac conduction disease. Europace 7:122–137CrossRef Smits JPP, Veldkamp MW, Wilde AAM (2005) Mechanisms of inherited cardiac conduction disease. Europace 7:122–137CrossRef
16.
Zurück zum Zitat Bonnar CE, Davie AP, Caruana L, Fenn L, Ogston SA, McMurray JJ, Struthers AD (1999) QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion. Heart 81:297–302CrossRef Bonnar CE, Davie AP, Caruana L, Fenn L, Ogston SA, McMurray JJ, Struthers AD (1999) QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion. Heart 81:297–302CrossRef
17.
Zurück zum Zitat Etheridge SP, Shaddy RE (2003) QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure. Am J Cardiol 91:1497–1500CrossRef Etheridge SP, Shaddy RE (2003) QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure. Am J Cardiol 91:1497–1500CrossRef
18.
Zurück zum Zitat Punn R, Lamberti JJ, Balise RR, Seslar SP (2011) QTc prolongation in children following congenital cardiac disease surgery. Cardiol Young 21:400–410CrossRef Punn R, Lamberti JJ, Balise RR, Seslar SP (2011) QTc prolongation in children following congenital cardiac disease surgery. Cardiol Young 21:400–410CrossRef
19.
Zurück zum Zitat Zhang ZM, Rautaharju PM, Prineas RJ, Loehr L, Rosamond W, Soliman EZ (2014) Usefulness of electrocardiographic QRS/T angles with versus without bundle branch blocks to predict heart failure (from the atherosclerosis risk in communities study). Am J Cardiol 114:412–418CrossRef Zhang ZM, Rautaharju PM, Prineas RJ, Loehr L, Rosamond W, Soliman EZ (2014) Usefulness of electrocardiographic QRS/T angles with versus without bundle branch blocks to predict heart failure (from the atherosclerosis risk in communities study). Am J Cardiol 114:412–418CrossRef
20.
Zurück zum Zitat Kass DA (2009) Pathobiology of cardiac dyssynchrony and resynchronization. Heart Rhythm 6:1660–1665CrossRef Kass DA (2009) Pathobiology of cardiac dyssynchrony and resynchronization. Heart Rhythm 6:1660–1665CrossRef
21.
Zurück zum Zitat Gorcsan J III, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, Martin R, Steinberg JS, St John Sutton M, Yu CM, Society of Echocardiography Dyssynchrony Writing Group (2008) Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting–a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 21:191–213CrossRef Gorcsan J III, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, Martin R, Steinberg JS, St John Sutton M, Yu CM, Society of Echocardiography Dyssynchrony Writing Group (2008) Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting–a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 21:191–213CrossRef
22.
Zurück zum Zitat Kantor PF, Mertens LL (2010) Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management. Eur J Pediatr 169:269–279CrossRef Kantor PF, Mertens LL (2010) Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management. Eur J Pediatr 169:269–279CrossRef
23.
Zurück zum Zitat Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, Shannon KM, Temple J, Rosenthal E, Zimmerman FJ, Davis A, Karpawich PP, Ahmad AA, Vetter VL, Kertesz N, Shah M, Snyder C, Stephenson E, Emmel M, Sanatani S, Kanter R, Batra A, Collins KK (2005) Resynchronization therapy in pediatric and congenital heart disease patients. JACC 46:2277–2283CrossRef Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, Shannon KM, Temple J, Rosenthal E, Zimmerman FJ, Davis A, Karpawich PP, Ahmad AA, Vetter VL, Kertesz N, Shah M, Snyder C, Stephenson E, Emmel M, Sanatani S, Kanter R, Batra A, Collins KK (2005) Resynchronization therapy in pediatric and congenital heart disease patients. JACC 46:2277–2283CrossRef
24.
Zurück zum Zitat Davey P (2000) QT interval lengthening in cardiac disease relates more to left ventricular systolic dysfunction than to autonomic function. Eur J Hear Fail 2:265–271CrossRef Davey P (2000) QT interval lengthening in cardiac disease relates more to left ventricular systolic dysfunction than to autonomic function. Eur J Hear Fail 2:265–271CrossRef
25.
Zurück zum Zitat Berul CI, Hill SL, Geggel RL, Hijazi ZM, Marx GR, Rhodes J, Walsh KA, Fulton DR (1997) Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol 8:1349–1356CrossRef Berul CI, Hill SL, Geggel RL, Hijazi ZM, Marx GR, Rhodes J, Walsh KA, Fulton DR (1997) Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol 8:1349–1356CrossRef
26.
Zurück zum Zitat Karatolios K, Holzendorf V, Richter A, Schieffer B, Pankuweit S, Competence Network Heart Failure Germany (2016) Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol 220:608–612CrossRef Karatolios K, Holzendorf V, Richter A, Schieffer B, Pankuweit S, Competence Network Heart Failure Germany (2016) Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol 220:608–612CrossRef
27.
Zurück zum Zitat Vrtovec B, Knezevic I, Poglajen G, Sebestjen M, Okrajsek R, Haddad F (2013) Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation. Am J Cardiol 111:886–890CrossRef Vrtovec B, Knezevic I, Poglajen G, Sebestjen M, Okrajsek R, Haddad F (2013) Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation. Am J Cardiol 111:886–890CrossRef
28.
Zurück zum Zitat Vrtovec B, Delgado R, Zewail A, Thomas CD, Richartz BM, Radovancevic B (2003) Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 107:1764–1769CrossRef Vrtovec B, Delgado R, Zewail A, Thomas CD, Richartz BM, Radovancevic B (2003) Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 107:1764–1769CrossRef
Metadaten
Titel
QTc and QRS Abnormalities are Associated with Outcome in Pediatric Heart Failure
verfasst von
Kandice Mah
Shiyi Chen
Gursimran Chandhoke
Paul F. Kantor
Elizabeth Stephenson
Publikationsdatum
18.05.2022
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 8/2022
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-022-02932-x

Weitere Artikel der Ausgabe 8/2022

Pediatric Cardiology 8/2022 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.